MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29 , 115–126

Bibliographic Details
Title: MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29 , 115–126
Authors: Neuzil, Jiri, Rohlena, Jakub, Werner, Lukas, Bielcikova, Zuzana
Source: Cancers; Sep2023, Vol. 15 Issue 18, p4476, 4p
Subject Terms: ANTINEOPLASTIC agents, MITOCHONDRIA, OXIDATIVE stress, MOLECULAR structure, TAMOXIFEN, PHOSPHORYLATION, PHARMACODYNAMICS
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:20726694
DOI:10.3390/cancers15184476
Published in:Cancers
Language:English